Delivery Order SPE2DB20D1004-SPE2DB25FNGGJ
Award Date
4/11/25
Potential Completion Date
4/14/25
Potential Value
$5.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp (AmerisourceBergen), a major pharmaceutical distributor and healthcare solutions provider, is for the delivery of Fingolimod 0.5 mg capsules. The contract, valued at $100,246.99, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has a period of performance through October 17, 2024. This is a delivery order contract with a firm fixed-price pricing type. The contract is not designated as a set-aside....
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $40,485.98, is for the delivery of FINGOLIMOD 0.5 MG CAPSULE 30S, a prescription medication, with a completion date of November 13, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4564377288 units of Fingolimod 0.5 mg capsules. The contract, valued at $33,275.45, was awarded on April 23, 2024 by the Defense Logistics Agency Troop Support Medical, with a completion date of April 24, 2024. This is a firm fixed-price delivery order contract, and there is no set-aside designation mentioned. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $40,817.40 firm-fixed-price contract is for the supply of FINGOLIMOD 0.5 MG CAPSULE 30S, a medication used to treat certain medical conditions. The contract has an ultimate completion date of January 6, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,535.90 firm fixed-price contract is for the delivery of FINGOLIMOD 0.5 MG CAPSULE 30S, with a period of performance through May 29, 2025. The contract award is not designated as a set-aside and was competitively awarded. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of FINGOLIMOD 0.5 MG CAPSULE 30S, a medication, with a ceiling value of $55,627.71 and a period of performance through June 5, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a for-profit organization that has a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of FINGOLIMOD 0.5 MG CAPSULE 30S, a neurological medication, with a ceiling value of $28,649.02. The contract is a firm fixed-price delivery order, with a performance period ending on May 6, 2025. This contract is not designated as a set-aside and was likely competed openly. AmerisourceBergen Drug Corp holds a...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Medical Supply Chain, a defense agency. The contract is for the delivery of Gilenya 0.5 mg capsules, a specialty medication, with a ceiling value of $26,943.61 and a performance period through October 2023. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
The federal contract award is for the delivery of 4566343663 FINGOLIMOD 0.5 MG CAPSULE 30S, a specialty pharmaceutical product. The contract, valued at $47,195.60, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is a Delivery Order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Gilenya 0.5 mg capsules to support medical supply needs. The $19,335.84 firm fixed-price contract was awarded on May 19, 2023 by the Defense Logistics Agency (DLA) Troop Support Medical with a completion date of May 22, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...